KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) EBT (2016 - 2025)

Historic EBT for Clorox (CLX) over the last 17 years, with Q4 2025 value amounting to $215.0 million.

  • Clorox's EBT fell 928.27% to $215.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $986.0 million, marking a year-over-year increase of 5239.57%. This contributed to the annual value of $1.1 billion for FY2025, which is 17085.43% up from last year.
  • Per Clorox's latest filing, its EBT stood at $215.0 million for Q4 2025, which was down 928.27% from $107.0 million recorded in Q3 2025.
  • Clorox's 5-year EBT high stood at $410.0 million for Q2 2025, and its period low was -$245.0 million during Q1 2023.
  • Over the past 5 years, Clorox's median EBT value was $133.0 million (recorded in 2022), while the average stood at $134.2 million.
  • As far as peak fluctuations go, Clorox's EBT plummeted by 22250.0% in 2023, and later soared by 70476.19% in 2025.
  • Clorox's EBT (Quarter) stood at $93.0 million in 2021, then surged by 39.78% to $130.0 million in 2022, then increased by 4.62% to $136.0 million in 2023, then surged by 74.26% to $237.0 million in 2024, then fell by 9.28% to $215.0 million in 2025.
  • Its EBT was $215.0 million in Q4 2025, compared to $107.0 million in Q3 2025 and $410.0 million in Q2 2025.